Veterinary Medicines

NOBILIS RHINO CV

Authorised
  • Turkey rhinotracheitis virus, strain 11/94, Live
Download as PDF

Product identification

Medicine name:
Nobilis Rhino CV
NOBILIS RHINO CV
Active substance:
  • Turkey rhinotracheitis virus, strain 11/94, Live
Target species:
  • Chicken (layer hen)
  • Chicken (for reproduction)
  • Chicken (broiler)
Route of administration:
  • Nasal use
  • Oculonasal use
  • Ocular use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain 11/94, Live
    31.62
    tissue culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension
Withdrawal period by route of administration:
  • Nasal use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
  • Oculonasal use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
  • Ocular use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
This information is not available for this product.
Package description:
  • Cardboard box containing 20 glass (Type I) vials of 25000 doses
  • Cardboard box containing 10 glass (Type I) vials of 25000 doses
  • Cardboard box containing 5 glass (Type I) vials of 25000 doses
  • Cardboard box containing 2 glass (Type I) vials of 25000 doses
  • Cardboard box containing 1 glass (Type I) vial of 25000 doses
  • Cardboard box containing 50 glass (Type I) vials of 10000 doses
  • Cardboard box containing 20 glass (Type I) vials of 10000 doses
  • Cardboard box containing 10 glass (Type I) vials of 10000 doses
  • Cardboard box containing 5 glass (Type I) vials of 10000 doses
  • Cardboard box containing 2 glass (Type I) vials of 10000 doses
  • Cardboard box containing 1 glass (Type I) vial of 10000 doses
  • Cardboard box containing 50 glass (Type I) vials of 5000 doses
  • Cardboard box containing 20 glass (Type I) vials of 5000 doses
  • Cardboard box containing 10 glass (Type I) vials of 5000 doses
  • Cardboard box containing 5 glass (Type I) vials of 5000 doses
  • Cardboard box containing 2 glass (Type I) vials of 5000 doses
  • Cardboard box containing 1 glass (Type I) vial of 5000 doses
  • Cardboard box containing 50 glass (Type I) vials of 2500 doses
  • Cardboard box containing 20 glass (Type I) vials of 2500 doses
  • Cardboard box containing 10 glass (Type I) vials of 2500 doses
  • Cardboard box containing 5 glass (Type I) vials of 2500 doses
  • Cardboard box containing 1 glass (Type I) vial of 2500 doses
  • Cardboard box containing 50 glass (Type I) vials of 1000 doses
  • Cardboard box containing 20 glass (Type I) vials of 1000 doses
  • Cardboard box containing 10 glass (Type I) vials of 1000 doses
  • Cardboard box containing 5 glass (Type I) vials of 1000 doses
  • Cardboard box containing 2 glass (Type I) vials of 1000 doses
  • Cardboard box containing 1 glass (Type I) vial of 1000 doses
  • Cardboard box containing 50 glass (Type I) vials of 500 doses
  • Cardboard box containing 20 glass (Type I) vials of 500 doses
  • Cardboard box containing 10 glass (Type I) vials of 500 doses
  • Cardboard box containing 5 glass (Type I) vials of 500 doses
  • Cardboard box containing 2 glass (Type I) vials of 500 doses
  • Cardboard box containing 1 glass (Type I) vial of 500 doses
  • Cardboard box containing 20 glass (Type I) vials of 250 doses
  • Cardboard box containing 10 glass (Type I) vials of 250 doses
  • Cardboard box containing 5 glass (Type I) vials of 250 doses
  • Cardboard box containing 2 glass (Type I) vials of 250 doses
  • Cardboard box containing 1 glass (Type I) vial of 250 doses
  • Cardboard box containing 2 glass (Type I) vials of 2500 doses
  • Cardboard box containing 50 glass (Type I) vials of 25000 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • MSD Animal Health Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • DGAV
Authorisation number:
  • R748/05 DGV
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0151/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."